Program
Discovery
Lead Optimization
IND-Enabling
Phase 1
Phase 2
Phase 3
Partner
PRA023 - Anti-TL1A mAb
PR600 - Anti-TNF Super Family Member mAb
Europe Partnered
PR300 - GPCR Modulator Small Molecule
TPR15 - mAb
Partnered

Prometheus has an early-stage discovery collaboration with Takeda Pharmaceuticals.

ProgramProgress
PRA023 Phase 1
PR600 Discovery
PR300 Discovery
TPR15 Discovery